Figure 3From: Stereotactic body radiotherapy in the treatment of Pancreatic Adenocarcinoma in elderly patientsLocal control for all patients from time of SBRT. Median LC was 11.5 months. Six-month and 12-month actuarial LC rates were 60.1% and 41.2%, respectively.Back to article page